INPEFA
NDC 70183-241, sotagliflozin, tablet, from Lexicon Pharmaceuticals, Inc..
- Product NDC
- 70183-241
- Status
- Listed
- Labeler
- Lexicon Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA216203
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70183-241 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SOTAGLIFLOZIN400 mg/1
Pharmacologic classes
P-Glycoprotein Inhibitors [MoA]; Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70183-241-30 | 70183024130 | 30 TABLET in 1 BOTTLE (70183-241-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1a46614e-05f6-421a-b6f4-d6f8760d643a
Use it
Look up 70183-241 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70183-241 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70183-241. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.